Short Interest in KORU Medical Systems, Inc. (NASDAQ:KRMD) Decreases By 35.0%

KORU Medical Systems, Inc. (NASDAQ:KRMD - Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 341,400 shares, a drop of 35.0% from the April 30th total of 525,200 shares. Based on an average daily volume of 151,100 shares, the days-to-cover ratio is presently 2.3 days. Currently, 0.8% of the company's stock are sold short.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. B. Riley raised KORU Medical Systems to a "strong-buy" rating in a research report on Thursday, March 13th. Piper Sandler dropped their price objective on KORU Medical Systems from $4.50 to $3.50 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, KORU Medical Systems has an average rating of "Buy" and an average target price of $4.50.

Institutional Investors Weigh In On KORU Medical Systems

Several institutional investors have recently added to or reduced their stakes in the business. Calamos Advisors LLC purchased a new position in shares of KORU Medical Systems in the fourth quarter worth about $250,000. White Pine Capital LLC raised its stake in shares of KORU Medical Systems by 25.6% in the fourth quarter. White Pine Capital LLC now owns 157,917 shares of the company's stock worth $608,000 after purchasing an additional 32,176 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new position in shares of KORU Medical Systems in the fourth quarter worth about $104,000. Raymond James Financial Inc. purchased a new position in shares of KORU Medical Systems in the fourth quarter worth about $118,000. Finally, HighTower Advisors LLC raised its stake in shares of KORU Medical Systems by 13.0% in the fourth quarter. HighTower Advisors LLC now owns 43,400 shares of the company's stock worth $167,000 after purchasing an additional 5,000 shares during the last quarter. Institutional investors and hedge funds own 58.60% of the company's stock.

KORU Medical Systems Stock Up 3.3%

NASDAQ KRMD traded up $0.09 during trading on Monday, hitting $2.79. The company's stock had a trading volume of 95,885 shares, compared to its average volume of 133,810. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37. The company has a market cap of $128.73 million, a PE ratio of -11.16 and a beta of 0.39. The business's 50 day simple moving average is $2.63 and its 200-day simple moving average is $3.41. KORU Medical Systems has a fifty-two week low of $1.86 and a fifty-two week high of $5.05.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The business had revenue of $9.64 million during the quarter, compared to analyst estimates of $8.86 million. KORU Medical Systems had a negative return on equity of 24.60% and a negative net margin of 37.42%. On average, equities analysts anticipate that KORU Medical Systems will post -0.13 EPS for the current fiscal year.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.